IDA Ireland today welcomes the commitment by Astellas, one of Japan’s largest life sciences companies and a leading developer and manufacturer of pharmaceutical products globally, to deliver a series of significant investments across its Irish operations. These investments, amounting to a total of €129m, over the next three years, reinforce the company’s long-term commitment to Ireland as a strategic hub for its global manufacturing, research, and development activities.
These investments are supported by the Irish Government through IDA Ireland.
Speaking from Tokyo where he met with members of the Astellas senior leadership team, Mr. Rao Mantri, Chief Manufacturing Officer and Mr. Yusuke Ishii, President of Astellas Ireland, Minister for Enterprise, Tourism and Employment, Peter Burke stated: “This commitment by Astellas highlights Ireland’s role in the global life sciences sector. Our ongoing investment in education, infrastructure, and innovation continues to create the optimum environment for companies to thrive. Astellas’ decision to grow its footprint in both Kerry and Dublin demonstrates the strength of Ireland’s offering and our commitment to supporting enterprise development across all regions.”
With a heritage in Ireland spanning more than 35 years, Astellas’ operations have a significant local impact and global reach. The company currently employs over 650 people in Ireland across two facilities in Killorglin and Mulhuddart, supplying medicines to 133 countries worldwide.
The multi-site investments, focusing on development, sustainability, and Research Development & Innovation (RD&I), aim to enhance Astellas’ operations across the country, further embedding its Irish footprint as a key pillar in the company’s global network.
Tralee, Co. Kerry
Killorglin, Co. Kerry
Astellas’ commitment to Ireland is a testament to the excellent record, past and present, of Astellas employees that have delivered for over 30 years across our Irish operations and the great relationship that Astellas has with the local community and local officials.”
Michael Lohan, CEO of IDA Ireland said: “This multi-site investment by Astellas is a strong endorsement of Ireland’s reputation as a global centre of excellence in life sciences and it exemplifies IDA Ireland’s strategic objectives to strengthen long term investment, scale cutting edge innovation, drive sustainable change and maximise regional opportunities. With its well-established talent base, robust infrastructure, and pro-business environment, Ireland continues to attract strategic investments from world-leading companies. Astellas’ long-standing presence here and its ongoing commitment to both Dublin and Kerry is a testament to the strength of our partnership and the value Ireland offers as a key location for innovation and growth.”
These investments are supported by the Irish Government through IDA Ireland.
Speaking from Tokyo where he met with members of the Astellas senior leadership team, Mr. Rao Mantri, Chief Manufacturing Officer and Mr. Yusuke Ishii, President of Astellas Ireland, Minister for Enterprise, Tourism and Employment, Peter Burke stated: “This commitment by Astellas highlights Ireland’s role in the global life sciences sector. Our ongoing investment in education, infrastructure, and innovation continues to create the optimum environment for companies to thrive. Astellas’ decision to grow its footprint in both Kerry and Dublin demonstrates the strength of Ireland’s offering and our commitment to supporting enterprise development across all regions.”
With a heritage in Ireland spanning more than 35 years, Astellas’ operations have a significant local impact and global reach. The company currently employs over 650 people in Ireland across two facilities in Killorglin and Mulhuddart, supplying medicines to 133 countries worldwide.
The multi-site investments, focusing on development, sustainability, and Research Development & Innovation (RD&I), aim to enhance Astellas’ operations across the country, further embedding its Irish footprint as a key pillar in the company’s global network.
Tralee, Co. Kerry
- Talent Development Plan: Astellas will undertake a comprehensive plan to equip employees with skills to address strategic challenges, focusing on leadership development, digital literacy, environmental sustainability, innovation, and compliance.
- RD&I Project: This project will enhance the production of antibody-drug conjugates and monoclonal antibodies, aiming to establish a high-efficiency, low-waste, multi-product biologics facility.
- Green Capital Project: A significant initiative designed to reduce energy use and lower CO₂ emissions. Planned upgrades include Heating, Ventilation, and Air Conditioning (HVAC) systems, a woodchip boiler, solar panels, and an on-site wastewater treatment plant.
Killorglin, Co. Kerry
- Green Projects: Astellas Killorglin will implement several initiatives to significantly reduce energy consumption and CO₂ emissions. These measures include wind turbines, woodchip boiler economisers, chiller upgrades, BioLPF/Hydrotreated Vegetable Oil (HVO) tanks, water heat pumps, and energy metering systems.
- Sustainability Enhancements: Astellas Damastown is embarking on a project to improve environmental sustainability through the installation of solar panels and heat pumps across multiple facilities. This transition to electricity for heating will substantially decrease carbon emissions.
Astellas’ commitment to Ireland is a testament to the excellent record, past and present, of Astellas employees that have delivered for over 30 years across our Irish operations and the great relationship that Astellas has with the local community and local officials.”
Michael Lohan, CEO of IDA Ireland said: “This multi-site investment by Astellas is a strong endorsement of Ireland’s reputation as a global centre of excellence in life sciences and it exemplifies IDA Ireland’s strategic objectives to strengthen long term investment, scale cutting edge innovation, drive sustainable change and maximise regional opportunities. With its well-established talent base, robust infrastructure, and pro-business environment, Ireland continues to attract strategic investments from world-leading companies. Astellas’ long-standing presence here and its ongoing commitment to both Dublin and Kerry is a testament to the strength of our partnership and the value Ireland offers as a key location for innovation and growth.”
